Miriam S. Jacob, MD

Article

In reply: The PARADIGM-HF trial

Author:

Miriam S. Jacob, MD

Publish date: March 1, 2016

The findings of PARADIGM-HF have sparked much conversation and implementation of practice change in the treatment of heart failure.

• Read More

Article

A new class of drugs for systolic heart failure: The PARADIGM-HF study

Author:

Miriam S. Jacob, MD

Publish date: October 1, 2015

Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.

• Read More